Clinical Trials Directory

Trials / Completed

CompletedNCT02215343

Effect of Prebiotic and PUFA on the Gut Microbiota and Metabolic Risk Markers

Effect of Prebiotic Fibre and Polyunsaturated Fatty Acid (PUFA) on the Gut Microbiota and Metabolic Risk Markers in a Metabolically Challenged Population

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
University of Copenhagen · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The main objective of this study is to investigate in detail how a high-(prebiotic)fibre diet and a high-PUFA diet affect the gut microbiota composition in a metabolic challenged population, and if the diet-induced modulation of the gut microbiota mediates changes in metabolic risk markers. Intake of both experimental diets over 4 weeks are expected to induce beneficial changes in the gut microbiota composition and to affect markers for insulin sensitivity, lipid metabolism and inflammation. The investigators hypothesize that the effect of both interventions on the metabolic risk markers will be partly mediated by the diet-induced changes in the gut microbiota composition.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTWheat bran extractPatients will be provided with 15g of wheat bran extract (WBE) (Cargill R\&D Centre Europe).
DIETARY_SUPPLEMENTFish oilPatients will be provided with a fish oil supplement (capsules), containing 3-4g of N-3 fatty acids (Axellus A/S, Ishøj, Denmark).

Timeline

Start date
2014-08-01
Primary completion
2015-06-01
Completion
2015-06-01
First posted
2014-08-13
Last updated
2020-05-20

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT02215343. Inclusion in this directory is not an endorsement.